CCWIP Home

  CDSS 5A - Use of Psychotropic Medications

Use of Psychotropic Medications

Please Note:

Data for the most recent time periods are considered preliminary due to lag times in reporting by Medi-Cal providers and plans. Additionally, Medi-Cal eligibility data are considered preliminary due to various adjustments made retroactively as additional information is ascertained.

New classes of medications specified in the Welfare and Institutions Code 369.5 (see below), including those with multiple indications, were included beginning in Quarter 4 of 2015 and all preceding time periods.

“Psychotropic medications are those medications administered for the purpose of affecting the central nervous system to treat psychiatric disorders or illnesses. These medications include, but are not limited to, anxiolytic agents, antidepressants, mood stabilizers, antipsychotic medications, anti-Parkinson agents, hypnotics, medications for dementia, and psychostimulants.”

Values of 10 or less and calculations based on values of 10 or less for the number of children on antipsychotic medications are masked (***). In stratified views of the data, additional values (the lowest available) are masked to prevent calculation of values of 10 or less.

The most recent available time periods for reports 5a (1&2) differ from reports on the rest of the site.

As well as the most recent available time periods data, these workbooks contain historical data. You may access other time periods by clicking on Excel worksheet tabs.



Correspondence regarding these CDSS-created tables should be sent to: CWSData@dss.ca.gov.
Please copy CCWIP at:
cssr-webmaster@berkeley.edu.